Диссертация (Использование молекулярно-генетических технологий в оценке риска возникновения ишемического инсульта и комплексных инструментальных подходов в диагностике и лечении у пациентов Западно-Сибирского региона), страница 26

– 2012. – V. 29, №6. – P. 741-750.140. Mi H. Polymorphisms in the PTX1 may not be associated with ischemicstrokesusceptibility /Hu W. //Int J ClinExp Med. 2014.V.7, №11. P. 3992-3999.141. Miossec P. Group for Respect of Ethics and Excellence in Science (GREES).Biomarkers and personalised medicine in rheumatoid arthritis: a proposal forinteractions between academia, industry and regulatory bodies /Verweij C.L.,Klareskog L., Pitzalis C., Barton A., Lekkerkerker F., Reiter S., Laslop A.,Breedveld F., Abadie E., Flamion B., Dere W., Mpofu S., Goel N., Ethgen D.,Mitlak B., Ormarsdóttir S., Rao R., Tsouderos Y., Reginster J.Y.; // Ann RheumDis.

– 2011. – V. 70, №10. – P. 1713-1718.142. Mishra S.K.The therapeutic value of yoga in neurological disorders /Singh P.,Bunch S.J., Zhang R.// Ann Indian Acad Neurol. – 2012. – V. 15, №4. – P. 24754.143. Mudzi W. Case fatality of patients with stroke over a 12-month period post stroke/Stewart A., Musenge E.// S Afr Med J. – 2012. – V.

102, №9. – P. 765-767.161144. Muiño E. An Inflammatory Polymorphisms Risk Scoring System fortheDifferentiation of Ischemic Stroke Subtypes /Krupinski J., Carrera C.,Gallego-Fabrega C., Montaner J., Fernández-Cadenas I. // Mediators Inflamm.2015. 569714.145. Mukherjee D. Epidemiology and the global burden of stroke /Patil C.G. // WorldNeurosurg. – 2011. – №76 (6 Suppl). – Р. 85-90.146. Norra C. Sleep disturbances and suicidality: a common association to look for inclinical practise and preventive care /Richter N., Juckel G. // EPMA J. –2011. –V.2, №3.

– P. 295–307.147. Oh C.H. Cerebrovascular disease and stroke in Korean male adolescent /ChungJ., Hyun D., Kim E., Park H.// Yonsei Med J. – 2012. – V. 53, №3. – P. 467-476.148. Orzuza G. Epidemiological aspects of stroke in very old patients /ZurrúM.C.//CardiovascHematolDisord Drug Targets. – 2011. – V.

11, №1. – P. 2-5.149. Patel S. A review of wearable sensors and systems with application inrehabilitation /Park H., Bonato P., Chan L., Rodgers M. // J NeuroengRehabil. –2012. – №9. – P. 21.150. Pirmohamed M. Pharmacogenetics: past, present and future //Drug Discov Today.– 2011.

– V. 16, №№19-20. – P. 852-861.151. Prasongchean W. Autologous stem cells for personalised medicine /Ferretti P. //N Biotechnol. – 2012. – V. 29, №6. – P. 641-650.152. Rhéaume C. Adiposity assessment: explaining the association between obesity,hypertension and stroke /Leblanc M.È., Poirier P. // Expert Rev CardiovascTher.– 2011. – V. 9, №12. – P. 1557-1564.153. Rigby M. Personal Health, Person-centred Health and Personalised Medicine Concepts, Consumers, Confusion and Challenges in the Informatics World //Yearb Med Inform. – 2012. – V.

7, №1. – P. 7-15.154. Romero J.R. Stroke prevention: modifying risk factors /Morris J., Pikula A. //TherAdvCardiovasc Dis. – 2008. – V. 2, №4. – P. 287–303.155. Romero J.R. Epidemiology of Stroke: Legacy of the Framingham Heart Study/Wolf P.A. // Glob Heart. – 2013. – V. 1, №8(1). – P. 67-75.162156. Ronteltap A. Nutrigenomics-based personalised nutritional advice: in search of abusiness model?/ van Trijp H., Berezowska A., GoossensJ.// Genes Nutr. –2013.– V.8, №2. – P. 153–163.157. Rutten-Jacobs L.C.

Common NOTCH3 Variants and Cerebral Small-VesselDisease /Traylor M., Adib-Samii P., Thijs V., Sudlow C., Rothwell P.M.,Boncoraglio G., Dichgans M., Bevan S., Meschia J., Levi C., Rost N.S., RosandJ., Hassan A., Markus H.S. //Stroke.2015. V. 46, №6. P. 1482-1487.158. Sahota P. Investigational Therapies for Ischemic Stroke: Neuroprotection andNeurorecovery /Savitz S.I. // Neurotherapeutics. – 2011. – V. 8, №3. – P. 434–451.159. Sawhney V.

Current Genomics in Cardiovascular Medicine /Brouilette S.,Abrams D., Schilling R., O’Brien B. // Curr Genomics. – 2012. - V 13, №6. – P.446–462.160. SchjetnanA.G.P.TranscranialDirectCurrentStimulationinStrokeRehabilitation: A Review of Recent Advancements /Faraji J., Metz G.A., TatsunoM., Luczak A. // Stroke Res Treat. – 2013. – P. 170256.161. Schmidt S. Patterned Brain Stimulation, What a Framework with Rhythmic andNoisy Components Might Tell Us about Recovery Maximization /Scholz M.,Obermayer K., Brandt S.A. // Front Hum Neurosci. – 2013. – №7. – P.

325.162. Schürks M. Association between polymorphisms in the beta2-adrenergic receptorgene with myocardial infarction and ischaemic stroke in women /Kurth T., RidkerP.M., Buring J.E., Zee R.Y. //ThrombHaemost. – 2009. – №101. – P. 351–358.163. Shetova I.M. The association between the DNA marker rs1842993 and risk forcardioembolic stroke in the Slavic population /Timofeev D.Iu., Shamalov N.A.,Bondarenko E.A., Slominskiĭ P.A., Limborskaia S.A., Skvortsova V.I. //ZhNevrolPsikhiatrIm S SKorsakova.

– 2012. – V. 112, №3 Pt 2. – P. 38-41.164. Shinton R. Meta-analysis of relation between cigarette smoking and stroke/Beevers G. // BMJ. – 1989. – №298. – P. 789–794.165. Singh N. Hypoxia inducible factor-1: its potential role in cerebral ischemia/Sharma G., Mishra V.// Cell MolNeurobiol. – 2012. –V. 32, №4. – P. 491-507.163166.

Soler E.P. Epidemiology and risk factors of cerebral ischemia and ischemic heartdiseases: similarities and differences/ Ruiz V.C.//CurrCardiol Rev. – 2010. – V.6, №3. – P. 138-149.167. Stanne T.M. Genetic variation at the BDNF locus: evidence for association withlong-term outcomeafter ischemic stroke /Tjärnlund-Wolf A., Olsson S., Jood K.,Blomstrand C., Jern C. //PLoS One. 2014.V.9, №12. e114156.168. Strazzullo P. Salt intake, stroke and cardiovascular disease: a meta-analysis ofprospective studies /D’Elia.L, Kandala N., Capuccio F.P.

// BMJ. – 2009. –№339. – P. 4567–4570.169. Stringhini S. Declining stroke and myocardial infarction mortality between 1989and 2010 in a country of the african region /Sinon F., Didon J., Gedeon J.,Paccaud F., Bovet P. // Stroke. – 2012. – V. 43, №9. – Р. 2283-2288.170. Stroke Statistics. 2009 Edition. British Heart Foundation Statistics Database.171. Stroke Statistics.

Stroke Association, 2013.172. Takeuchi N. Izumi S.-I. Rehabilitation with Poststroke Motor Recovery: AReview with a Focus on Neural Plasticity // Stroke Res Treat. – 2013. – P.128641.173. Tolstrup J., Prospective study of alcohol drink patterns and coronary heart diseasein women and men /Jensen M.K., Tjonneland A., Overvard K., Mukamal K.J.,Gronbaek M.// BMJ. – 2006. – №332. – P.

1244–1248.174. Traylor M., (2012)Genetic risk factors for ischaemic stroke and its subtypes (theMETASTROKE Collaboration): a meta-analysis of genome-wide associationstudies /Farrall M., Holliday E.G., Sudlow C., Hopewell J.C., et al. // LancetNeurol. – 2012.

– №11. – P. 951–962.175. Tummers J.F.M.M., Economic evidence on integrated care for stroke patients; asystematic review /Schrijvers A.J.P, Visser-Meily J.M.A. // Int J Integr Care. –2012. – №12. – P. e193.176. Turtzo C., Sex Differences in Stroke /McCullough L.D.

// Cerebrovasc Dis. –2008. – V. 26, №5. – P. 462–474.164177. Voetsch B., Promoter Polymorphisms in the Plasma Glutathione Peroxidase(GPx-3) Gene: A Novel Risk Factor for Arterial Ischemic Stroke among YoungAdults and Children /Jin R.C., Bierl C., Benke K.S., Kenet G., Simioni P.,Ottaviano F., Damasceno B.P., Annichino-Bizacchi J.M., Handy D.E., LoscalzoJ.

// Stroke. – 2007. – V. 38, №1. – P. 41–49.178. Waje-Andreassen U., Biomarkers Related to Carotid Intima-Media Thickness andPlaques inLong-Term Survivors of Ischemic Stroke /Naess H., Thomassen L.,Maroy T.H., Mazengia K.Y., Eide G.E., Vedeler C.A.//Transl Stroke Res. 2015.V.6, №4. P. 276-283.179. Wang M., Endothelial NO synthase gene polymorphisms and risk of ischemicstroke in Asian population: a meta-analysis /Jiang X., Wu W, Zhang D. // PLoSOne. – 2013. – V. 8, №3. – P. e60472.180.

Wei L.K., A potential epigenetic marker mediating serum folate and vitamin B12levels contributes to the risk of ischemic stroke /Sutherland H., Au A., CamilleriE., Haupt L.M., Gan S.H., Griffiths L.R. // Biomed Res Int. 2015. P. 167976.181.

Williams F.M.K., Ischemic Stroke Is Associated with the ABO Locus: TheEuroCLOT Study /Carter A.M., Hysi P.G., Surdulescu G., Hodgkiss D., et al. //Ann Neurol. – 2013. – V. 73, №1. – P. 16–31.182. Xu G., Is there a stroke belt in china and why? /Ma M., Liu X., Hankey G.J. //Stroke. – 2013. –V. 44, №7.

– Р. 1775-1783.183. Yadav S., Detailed Analysis of Gene Polymorphisms Associated with IschemicStroke in South Asians /Hasan N., Marjot T., Khan M.S., Prasad K., Bentley P.,Sharma P. // PLoS One. – 2013. – V. 8, №3. – P. e57305.184. Yamase Y., Association of TOMM40 and SLC22A4 polymorphisms withischemic stroke /Horibe H., Ueyama C., Fujimaki T., Oguri M., Kato K., Arai M.,Watanabe S., Yamada Y. // Biomed Rep. 2015.

V.3, №4. P. 491-498.185. Yang N.Y.H., Rehabilitation Interventions for Unilateral Neglect after Stroke: ASystematic Review from 1997 through 2012 /Zhou D., Chung R.C.K., Li-TsangC.W.P., Fong K.N.K. // Front Hum Neurosci. – 2013. – №7. – P. 187.165186. You R.X., Melbourne Stroke Risk Factor Study (MERFS) Group. Ischemic strokerisk and passive exposure to spouses' cigarette smoking /Thrift A.G., McNeil J.J.,Davis S.M., Donnan G.A. //Am J Public Health. – 1999.

– №89. – P. 572–575.187. Zhang G., Association between paraoxonase gene and stroke in the Han Chinesepopulation /Li W., Li Z., Lv H., Ren Y., Ma R.,Li X., Kang X., Shi Y., Sun Y. //BMC Med Genet. – 2013. – №14. – P. 16.188. Zhang S.-y., Association of ALOX5AP gene single nucleotide polymorphismsand cerebral infarction in the Han population of northern China /Xu M.-l., ZhangC.-e, Qu Z.-y., Zhang B.-b., Zheng Z.-y., Zhang L.-m. // BMC Med Genet. –2012. – №13. – P. 61.189. Zhang Z., Angiotensin-converting enzyme insertion/deletion polymorphismcontributes to ischemic stroke risk: a meta-analysis of 50 case-control studies /XuG., Liu D., Fan X., Zhu W., Liu X.// PLoS One. – 2012. – V.

7, №10. – P.e46495..